.
MergerLinks Header Logo

New Deal


Announced

Completed

Paine Schwartz Partners-backed Lyons Magnus completed the acquisition of TRU Aseptics.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

aseptic manufacturer

United States

Medical Supplies

Acquisition

Majority

Domestic

Completed

Friendly

Single Bidder

Private

Private Equity

Synopsis

Edit

Paine Schwartz Partners-backed Lyons Magnus, a developer and manufacturer of fruit and flavor solutions for the food service, healthcare and dairy industries, completed the acquisition of TRU Aseptics, a manufacturer of aseptic products. Financial terms were not disclosed. "The addition of TRU is an important strategic step for Lyons Magnus that provides access to the high-growth sector of low-acid aseptic products. TRU's advanced facility and our highly experienced team will accelerate our entrance into this exciting market, allowing us to further support our current foodservice and healthcare customers, as well as pursue new opportunities in those and other channels. We look forward to working closely with Stacey and the TRU team to build upon TRU's capabilities and offer customers products in this on-trend category to meet consumers' demand for items such as plant-based milks and high-protein beverages," Ed Carolan, Lyons Magnus CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US